<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04491786</url>
  </required_header>
  <id_info>
    <org_study_id>GiaDinhPH</org_study_id>
    <nct_id>NCT04491786</nct_id>
  </id_info>
  <brief_title>The Efficacy of Postoperative Analgesia of Gabapentin Plus Nefopam in the Spinal Surgery</brief_title>
  <official_title>Department of Anaesthesiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gia Dinh People Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gia Dinh People Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The acute pain after spinal surgery is serious. The most pain is during 24 hours after&#xD;
      surgery. The multimodal therapy is a method which is applied to treat the postoperative pain.&#xD;
&#xD;
      Morphine is main analgesic to treat postoperative pain. However, some the side-effects can&#xD;
      occur to patients and there are associate with dosage. So, some analgesics usually combinate&#xD;
      with morphine to postoperative analgesia, include gabapentin, celecoxib, ketamine, ...&#xD;
&#xD;
      Nefopam is a central analgesic. There are effect prevent hyperalgesia. The effect of the&#xD;
      combination of gabapentin with nefopam to postoperative analgesia in spinal surgery hasn't&#xD;
      been reported yet.&#xD;
&#xD;
      The gabapentin oral with 600 mg combine with continuously intravenous nefopam with 65&#xD;
      µg/kg/hour during 24 hours after spinal surgery whether to increase the effect of&#xD;
      postoperative analgesia.&#xD;
&#xD;
      The investigators hypothesized that the gabapentin oral with 600 mg combine with continuously&#xD;
      intravenous nefopam with 65 µg/kg/hour during 24 hours after spinal surgery can decrease 40%&#xD;
      of the consumption of morphine during 24 hours.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After enrolled, all participants will randomly assigned into the two groups. The intervention&#xD;
      group (GAPA-group) will treated preoperative oral 600 mg of gabapentin. After general&#xD;
      anesthesia, all participants of both groups will continuously transfused 65 µg/kg/hour of&#xD;
      nefopam during 24 hours. After surgery, all cases will treated analgesia with morphine-PCA (2&#xD;
      mg of singe dose, 5 minutes of lockout time, and 6 mg of one hour).&#xD;
&#xD;
      The efficacy of postoperative analgesia will evaluated with the consumption of morphine&#xD;
      during 24 hours.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Actual">May 31, 2021</completion_date>
  <primary_completion_date type="Actual">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The intervention group will treated postoperative analgesia with 600 mg of gabapentin plus 65 mcg/kg/hour during 24 hours of nefopam</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Consumption of morphine</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Concentration of morphine that participant use during postoperative 24 hours with PCA (mg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side-effect</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>The rate of side-effect induced gabapentin, nefopam, and morphine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Spinal Fusion</condition>
  <arm_group>
    <arm_group_label>GAPA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will treated with preoperative 600 mg of gabapentin plus nefopam which will continuously transfused during intraoperative and postoperative 24 hours, and morphine-PCA during postoperative 24 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-GAPA</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will treated with nefopam which will continuously transfused during intraoperative and postoperative 24 hours, and morphine-PCA during postoperative 24 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Gabapentin plus nefopam</description>
    <arm_group_label>GAPA</arm_group_label>
    <other_name>Nefopam</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age from 18 to 70.&#xD;
&#xD;
          -  Spinal selective surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy one of drugs in study.&#xD;
&#xD;
          -  Neurological disorder.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Binh V. Huynh</last_name>
    <role>Study Chair</role>
    <affiliation>Nhan dan Gia Dinh Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Binh Huynh</name>
      <address>
        <city>Ho Chi Minh City</city>
        <state>Ho Chi Minh</state>
        <zip>70000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>July 26, 2020</study_first_submitted>
  <study_first_submitted_qc>July 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2020</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gabapentin</keyword>
  <keyword>Nefopam</keyword>
  <keyword>Spinal surgery</keyword>
  <keyword>Postoperative analgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Nefopam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

